Immunological correlates of protection mediated by a whole organism Cryptococcus neoformans vaccine deficient in chitosan
Charles Specht,Ruiying Wang,Lorena V. N. Oliveira,Maureen M Hester,Christina L Gomez,Zhongming Mou,Diana Carlson,Chrono K Lee,Camaron R Hole,Woei C Lam,Rajendra Upadhya,Jennifer Lodge,Stuart M Levitz
DOI: https://doi.org/10.1101/2024.06.12.598760
2024-06-14
Abstract:The global burden of infections due to the pathogenic fungus Cryptococcus is substantial in persons with low CD4 T cell counts. Previously, we deleted three chitin deacetylase genes from C. neoformans to create a chitosan-deficient, avirulent strain, designated cda1Δ2Δ3Δ which, when used as a vaccine, protected mice from challenge with virulent C. neoformans strain KN99. Here, we explored the immunological basis for protection. Vaccine-mediated protection was maintained in mice lacking B cells or CD8 T cells. In contrast, protection was lost in mice lacking α/β T cells or CD4 T cells. Moreover, CD4 T cells from vaccinated mice conferred protection upon adoptive transfer to naive mice. Importantly, while monoclonal antibody-mediated depletion of CD4 T cells just prior to vaccination resulted in complete loss of protection, significant protection was retained in mice depleted of CD4 T cells after vaccination, but prior to challenge. Vaccine-mediated protection was lost in mice genetically deficient in IFNγ, TNFα, or IL-23p19. A robust influx of leukocytes and IFNγ- and TNFα-expressing CD4 T cells was seen in the lungs of vaccinated and challenged mice. Finally, a higher level of IFNγ production by lung cells stimulated ex vivo correlated with lower fungal burden in the lungs. Thus, while B cells and CD8 T cells are dispensable, IFNγ and CD4 T cells have overlapping roles in generating protective immunity prior to cda1?2?3? vaccination. However, once vaccinated, protection becomes less dependent on CD4 T cells, suggesting a strategy for vaccinating HIV persons prior to loss of CD4 T cells.
Immunology